# Heather A. Wakelee

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/heather-a-wakelee/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,438 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 88 |
| i10-index | 297 |
| Last Known Institution | Cancer Prevention Institute of California |
| OpenAlex ID | https://openalex.org/A5035640724 |
| ORCID iD | 0000-0003-1136-980X |
| Works | 959 |

## Researcher papers

Showing 12 of 19.

- [An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage](https://scholariq.org/papers/an-ultrasensitive-method-for-quantitating-circulating-tumor-dna-with-broad/)
- [Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial](https://scholariq.org/papers/adjuvant-atezolizumab-after-adjuvant-chemotherapy-in-resected-stage-ib-iiia-non/)
- [Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry](https://scholariq.org/papers/immune-checkpoint-inhibitors-for-patients-with-advanced-lung-cancer-and/)
- [Integrated digital error suppression for improved detection of circulating tumor DNA](https://scholariq.org/papers/integrated-digital-error-suppression-for-improved-detection-of-circulating-tumor/)
- [Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling](https://scholariq.org/papers/early-detection-of-molecular-residual-disease-in-localized-lung-cancer-by/)
- [Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer](https://scholariq.org/papers/perioperative-pembrolizumab-for-early-stage-non-small-cell-lung-cancer/)
- [Integrating genomic features for non-invasive early lung cancer detection](https://scholariq.org/papers/integrating-genomic-features-for-non-invasive-early-lung-cancer-detection/)
- [Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC](https://scholariq.org/papers/liquid-biopsy-for-advanced-non-small-cell-lung-cancer-nsclc-a-statement-paper/)
- [Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer](https://scholariq.org/papers/rociletinib-in-i-egfr-i-mutated-non-small-cell-lung-cancer/)
- [Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer](https://scholariq.org/papers/liquid-biopsy-for-advanced-nsclc-a-consensus-statement-from-the-international/)
- [Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients](https://scholariq.org/papers/circulating-tumour-dna-profiling-reveals-heterogeneity-of-egfr-inhibitor/)
- [COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study](https://scholariq.org/papers/covid-19-in-patients-with-thoracic-malignancies-teravolt-first-results-of-an/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Cancer Prevention Institute of California](https://scholariq.org/institutions/cancer-prevention-institute-of-california/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.